| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Total revenues [+] | 326.6 | 280.6 | 264.5 | 274.6 | 280.4 | 276.9 | 267.3 | 182.2 |
| Products | | | | | | | | 118.4 |
| Services | | | | | | | | 63.8 |
| Revenue growth [+] | 16.4% | 6.1% | -3.7% | -2.1% | 1.3% | 3.6% | 46.7% | -11.0% |
| Electronic health record | 585.4% | -85.1% | | | | | | |
| Cost of goods sold [+] | 172.2 | 139.7 | 128.2 | 130.5 | 130.7 | 129.7 | 133.5 | 87.7 |
| Cost of product sales | | | | | | | 87.9 | 52.5 |
| Cost of services | | | | | | | 45.7 | 35.2 |
| Cost of services, excluding D&A | | | | | | | 45.7 | |
| Gross profit | 154.4 | 140.9 | 136.2 | 144.1 | 149.7 | 147.3 | 133.7 | 94.5 |
| Gross margin | 47.3% | 50.2% | 51.5% | 52.5% | 53.4% | 53.2% | 50.0% | 51.9% |
| Selling, general and administrative [+] | 83.3 | 72.0 | 70.3 | 71.7 | 78.0 | 79.9 | 80.1 | 55.1 |
| Sales and marketing | 27.1 | 22.0 | 22.8 | 26.5 | 30.7 | 33.0 | 27.2 | 18.3 |
| General and administrative | 56.2 | 50.0 | 47.5 | 45.2 | 47.3 | 46.9 | 52.9 | 36.8 |
| Research and development | 30.9 | 30.4 | 33.5 | 36.9 | 36.4 | 33.7 | 29.1 | 14.2 |
| Other operating expenses | -0.6 | | | -5.0 | | | 10.2 | |
| EBITDA [+] | 46.7 | 41.6 | 34.4 | 42.0 | 37.2 | 36.1 | 27.6 | 28.3 |
| EBITDA growth | 12.3% | 20.9% | -18.1% | 13.0% | 3.0% | 30.6% | -2.3% | -46.9% |
| EBITDA margin | 14.3% | 14.8% | 13.0% | 15.3% | 13.3% | 13.0% | 10.3% | 15.5% |
| Depreciation | 5.9 | 3.1 | 1.9 | 1.4 | 1.8 | 2.5 | 3.1 | 3.2 |
| EBITA | 40.8 | 38.5 | 32.5 | 40.6 | 35.4 | 33.6 | 24.6 | 25.1 |
| EBITA margin | 12.5% | 13.7% | 12.3% | 14.8% | 12.6% | 12.1% | 9.2% | 13.8% |
| Amortization of intangibles | 17.4 | 13.8 | 11.4 | 11.0 | 10.5 | 10.4 | 10.2 | |
| EBIT [+] | 23.3 | 24.7 | 21.1 | 29.6 | 24.9 | 23.2 | 14.4 | 25.1 |
| EBIT growth | -5.5% | 17.4% | -28.8% | 18.9% | 7.3% | 61.3% | -42.7% | -49.4% |
| EBIT margin | 7.1% | 8.8% | 8.0% | 10.8% | 8.9% | 8.4% | 5.4% | 13.8% |
| Non-recurring items [+] | 0.6 | | | 5.0 | | 28.0 | | |
| Asset impairment | | | | | | 28.0 | | |
| Unusual expense | 0.6 | | | 5.0 | | | | |
| Interest expense | 6.3 | 3.2 | 3.6 | 6.7 | 7.6 | 7.7 | 6.6 | |
| Interest expense | 6.3 | 3.2 | 3.6 | 6.7 | 7.6 | 7.7 | 6.6 | |
| Other income (expense), net [+] | 1.6 | 1.5 | 1.3 | 5.8 | 0.8 | -0.9 | 0.2 | 0.4 |
| Gain (loss) on debt retirement | -0.1 | | -0.2 | | | -1.3 | | |
| Other non-operating income | 1.2 | 1.5 | 1.5 | 0.8 | 0.8 | 0.4 | 0.2 | 0.4 |
| Other | -4.7 | -1.6 | -2.3 | 0.8 | 0.8 | 0.4 | 0.2 | 0.4 |
| Pre-tax income | 18.1 | 23.1 | 18.8 | 23.7 | 18.1 | -13.5 | 8.0 | 25.5 |
| Income taxes | 2.2 | 4.6 | 4.5 | 3.2 | 0.5 | 3.9 | 4.1 | 7.1 |
| Tax rate | 12.2% | 20.1% | 24.2% | 13.6% | 2.6% | | 50.8% | 28.0% |
| Net income | 15.9 | 18.4 | 14.2 | 20.5 | 17.6 | -17.4 | 3.9 | 18.3 |
| Net margin | 4.9% | 6.6% | 5.4% | 7.5% | 6.3% | -6.3% | 1.5% | 10.1% |
| |
| Basic EPS [+] | $1.11 | $1.29 | $1.01 | $1.49 | $1.30 | ($1.30) | $0.30 | $1.66 |
| Growth | -14.3% | 27.1% | -31.7% | 14.3% | -200.2% | -537.4% | -82.1% | -44.6% |
| Diluted EPS [+] | $1.11 | $1.29 | $1.01 | $1.49 | $1.30 | ($1.30) | $0.30 | $1.66 |
| Growth | -14.1% | 26.8% | -31.7% | 14.3% | -200.1% | -537.4% | -82.1% | -44.6% |
| |
| Dividends per share [+] | | | $0.31 | $0.42 | $0.41 | $0.87 | $1.89 | $2.61 |
| Growth | | -100.0% | -25.7% | 0.3% | -52.2% | -54.2% | -27.5% | 12.8% |
| |
| Shares outstanding (basic) [+] | 14.4 | 14.3 | 14.0 | 13.8 | 13.6 | 13.4 | 13.3 | 11.1 |
| Growth | 0.5% | 1.8% | 1.9% | 1.6% | 1.1% | 1.2% | 19.6% | 0.5% |
| Shares outstanding (diluted) [+] | 14.4 | 14.3 | 14.0 | 13.8 | 13.6 | 13.4 | 13.3 | 11.1 |
| Growth | 0.3% | 2.0% | 1.9% | 1.5% | 1.1% | 1.2% | 19.6% | 0.5% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |